You are here

AstraZeneca

AstraZeneca dismisses rumors of facility relocation to US

Pharmaphorum

Fri, 08/23/24 - 10:44 am

drug manufacturing

AstraZeneca warns of shifting UK vaccine production to US, FT reports

Reuters

Thu, 08/22/24 - 09:57 pm

Targeting AZ's Tagrisso, Johnson & Johnson's Rybrevant combo wins key FDA nod in first-line lung cancer

Fierce Pharma

Tue, 08/20/24 - 11:36 am

non-small cell lung cancer

EU starts review of Enhertu in HER2-ultra-low breast cancer

Pharmaphorum

Mon, 08/19/24 - 09:56 am

US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case

Fierce Pharma

Thu, 08/15/24 - 10:33 pm

Patent Infringement

FDA approves AstraZeneca's non-small cell lung cancer treatment

Reuters

Thu, 08/15/24 - 10:06 pm

non-small cell lung cancer

AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for Endometrial Cancer

BioSpace

Wed, 08/14/24 - 10:58 am

endometrial cancer

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Conduit bets on three of AstraZeneca’s potential first-in-class assets

First Word Pharma

Thu, 08/8/24 - 11:06 am

Conduit Pharmaceuticals

3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field

Fierce Pharma

Mon, 08/5/24 - 11:41 am

Gilead Sciences

clinical trials

antibody-drug conjugates

Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market

Motley Fool

Sun, 08/4/24 - 06:30 pm

After tense standoff, AstraZeneca and Daiichi's Enhertu turned away by NICE on pricing grounds

Fierce Pharma

Mon, 07/29/24 - 10:51 am

HER2-low breast cancer

FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trials

Fierce Pharma

Thu, 07/25/24 - 09:59 pm

clinical trials

non-small cell lung cancer

Trials to watch: Four biologics concluding pivotal COPD trials

Clinical Trials Arena

Thu, 07/25/24 - 11:36 am

clinical trials

AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines

Yahoo/Benzinga

Thu, 07/25/24 - 11:07 am

FDA Flags Potential ‘Overtreatment’ for NSCLC With AstraZeneca’s Imfinzi Ahead of Adcomm

BioSpace

Wed, 07/24/24 - 11:32 am

non-small cell lung cancer

AstraZeneca plants an EGFR tree with Pinetree deal worth $45M

Fierce Biotech

Tue, 07/23/24 - 06:24 pm

Pinetree Therapeutics

J&J, BMS and AstraZeneca strike back in appeals after IRA litigation losses

Fierce Pharma

Tue, 07/16/24 - 12:00 pm

Inflation Reduction Act

Bristol Myers Squibb

AstraZeneca appoints WPP as one of its primary oncology network partners

Medical Marketing and Media

Wed, 07/10/24 - 11:15 am

Pages